GP IIb/IIIa Antagonists

All the drugs appearing in the Adis Profile Summary table have been selected based on information contained in R&D Insight^TM, a proprietary product of Adis International. As the emphasis of Drugs in R&D is on the clinical potential of new drugs, selection of agents for a full profile is based on the extensiveness of available data. Information on all drugs in clinical development, as identified fromR&D Insight^TM, is included in the summary table. Information and/or profiles of agents in preclinical development may be included as appropriate.